M. Y. acknowledges the funding from the Postgraduate Research &#38; Practice Innovation Program of Jiangsu Province, China (Grant No. KYCX22_2803). L.K. is thankful for the support of the Natural Science Research of Jiangsu Higher Education Institutions of China, China (Grant No. 17KJB180003), the Natural Science Foundation of Jiangsu Normal University, China (Grant No. 17XLR037), Priority Academic Program Development of Jiangsu Higher Education Institutions, China, and the Jiangsu Specially-Appointed Professor program, China.

1. Extract preparation
<ol>
	<li>Streak the E. coli BL21 (DE3) strain from a glycerol stock onto a Luria Bertani (LB) agar plate and incubate for at least 15 h at 37 &#176;C.</li>
	<li>Prepare an overnight preculture by inoculating a single colony from the freshly prepared LB plate into a 50 mL flask of Luria Bertani (LB) medium.</li>
	<li>Inoculate 5 mL of preculture into 500 mL of 2xYTPG medium in a 3 L baffled Erlenmeyer flask. Grow it at 37 &#176;C with vigorous shaking (between 220 rpm and 250 rpm) and harvest the cells when they reach the mid-log phase (OD600 ~ 3). Then, place the cell cultures in cold icy water for 10 min and centrifuge at 8,000 &#215; g for 15 min at 4 &#176;C. 
	NOTE: In this step, the glucose in 2xYTPG medium can be omitted for specific applications9,12.</li>
	<li>Resuspend the resulting cell pellets in 35 mL of prechilled S30 buffer A, followed by centrifugation at 8,000 &#215; g for 15 min at 4 &#176;C. Discard the supernatant.</li>
	<li>Repeat step 1.4 twice. 
	NOTE: The cell pellets can be stored at -80 &#176;C if not used immediately.</li>
	<li>Resuspend the final pellets in S30 buffer B (e.g., use 1.1 mL of S30 buffer B per 1 g of cell pellet) and disrupt the cells by one pass through French Press at 17,000 psi.
	<ol>
		<li>For using the French Press, follow the user manual and transfer the cell suspension to the French press metal disruption chamber, ensuring that all components are assembled and the bottom valve of the disruption chamber is closed.</li>
		<li>Transfer the assembled disruption chamber to the hydraulic platform and secure the safety lock.</li>
		<li>Turn on the hydraulic pump and start the disruption.</li>
		<li>Control the outlet valve to enable the cell suspension to flow out of the outlet tube into a new 50 mL tube. Adjust the flow speed to ensure efficient disruption, ideally one drop at a time. Maintain the pressure above the lower limit of 15,000 psi.</li>
	</ol>
	</li>
	<li>Centrifuge the resulting lysate at 30,000 &#215; g for 30 min at 4 &#176;C and collect the supernatant. Repeat the centrifugation once and collect the supernatant. Add 0.3 volume of preincubation buffer into the collected supernatant and incubate with gentle shaking at 37 &#176;C for 80 min. 
	NOTE: The use of preincubation buffer could increase the final yield though it has been reported that an empty run-off (without preincubation buffer) could also improve the efficiency37,38, which depends on the corresponding source strain.</li>
	<li>Dialyze the resulting run off mixture for 2 h against 2 L of S30 buffer C, exchange the dialysis buffer once with 2 L of fresh S30 buffer C, and dialyze overnight at 4 &#176;C39. 
	NOTE: The second step of overnight dialysis can be shortened to approximately 3 h.</li>
	<li>Collect the dialyzed sample and centrifuge at 30,000 &#215; g for 30 min at 4 &#176;C. Collect the supernatant and aliquot into appropriate volumes and flash freeze immediately in liquid nitrogen. 
	NOTE: The frozen sample can be stored at -80 &#176;C at least for 6 months to 1 year without loss of efficiency.</li>
</ol>
2. T7 RNA polymerase
<ol>
	<li>Transform pAR1219 plasmid into BL21(DE3) star E. coli competent cells40.</li>
	<li>Inoculate 10 mL of an overnight culture into 1 L of LB medium (containing 100 &#181;g/mL ampicillin). Grow the cells at 37 &#176;C until OD600 reaches 0.6-0.8.</li>
	<li>Start the induction by adding a final concentration of 1 mM IPTG. Induce the cells for an additional 5 h and harvest by centrifugation at 8,000 &#215; g for 15 min at 4 &#176;C. Store the cell pellets at -80 &#176;C for up to several weeks.</li>
	<li>Resuspend the cell pellets in 30 mL of T7 buffer A and disrupt the cells by one pass through the French Press at 15,000 psi. Remove the cell debris by centrifugation at 20,000 &#215; g for 30 min at 4 &#176;C.</li>
	<li>Add streptomycin sulfate drop by drop to the supernatant from the previous step, reaching a final concentration of 4% (w/v). After a short incubation on ice, centrifuge at 20,000 &#215; g for 30 min at 4 &#176;C.</li>
	<li>Filter the supernatant through a 0.45 &#181;m filter membrane and load the filtered sample onto a strong anion exchange column (column volume of 40 mL), which was preequilibrated with 10 column volumes of T7 buffer B, via an automated liquid chromatograph system.</li>
	<li>Wash the loaded column with 50 column volumes of T7 buffer B and elute the sample with 10 column volumes of low salt (50 mM NaCl) and high salt (500 mM) T7 buffer C mixtures, establishing a linear concentration gradient of NaCl from 50 to 500 mM at a flow rate of ~3 mL/min41.</li>
	<li>Collect the peak fractions and analyze by SDS-PAGE. 
	NOTE: T7 polymerase exhibits a predominate band at ~100 kDa, while significant amounts of impurities still appear on the SDS-PAGE gel.</li>
	<li>Pool the fractions containing T7 polymerase and dialyze against 2 L of T7 buffer C overnight.</li>
	<li>Add glycerol to reach a final concentration of 10% and concentrate the resulting mixture to a final concentration of 3-4 mg/mL by ultrafiltration42. 
	NOTE: If precipitation appears during the concentration process, stop immediately and remove the precipitates by centrifugation.</li>
	<li>Adjust the glycerol concentration to 50%. Aliquot and flash freeze the sample with liquid nitrogen. Store at &#8722;80 &#176;C for a longer period. 
	NOTE: A small aliquot could also be stored at -20 &#176;C for at least 1 month without loss of efficiency.</li>
</ol>
3. Buffer preparation
<ol>
	<li>Prepare buffers as indicated in Table 1 a day before usage.</li>
</ol>
4. Template design and preparation
<ol>
	<li>Clone the gene of interest into a T7 promoter-based vector or generate a linear PCR product containing the gene of interest. 
	NOTE: See the discussion section for design principles.</li>
	<li>Prepare the plasmid from an overnight culture using a plasmid extraction kit. 
	NOTE: We recommend selecting a plasmid kit that includes an isopropanol precipitation step followed by a washing procedure with 70% ethanol.</li>
	<li>Dissolve the dried DNA in a small volume of ultrapure water to a concentration between 200 &#181;g/mL and 500 &#181;g/mL, as determined by a micro volume spectrophotometer.</li>
	<li>Optional: Directly express proteins from linear PCR products. 
	NOTE: In this case, a PCR purification step is needed.</li>
</ol>
5. Mg2+ and K+ optimization
<ol>
	<li>Prepare a master mix for Mg2+ concentration screening as indicated in Table 2, or for K+ concentration screening as indicated in Table 3.</li>
	<li>Transfer the master mix into individual microfuge tubes or a V-shaped 96-well plate.</li>
	<li>Pipette the exact volume of Mg2+ or K+ stock solutions into individual microfuge tubes or the V-shaped 96-well plate and complete the CFPS reactions with ultrapure water. Incubate the reactions for at least 2 h. 
	NOTE: If using a V-shaped 96-well plate, seal the plate with a plastic cover to prevent evaporation.</li>
	<li>Take out 2 &#181;L of the reaction mixture and transfer into a black 96-well plate for fluorescence measurements by a plate reader. 
	NOTE: We use a fluorescent plate reader with the following setup: excitation/emission: 485/528, Gain: 50, Read height: 7.00 mm. However, one would need to tune their plate reader to generate a specific calibration curve using purified fluorescent proteins.</li>
</ol>
6. Encapsulation
<ol>
	<li>Droplet
	<ol>
		<li>Prepare a surfactant-containing fluorinated oil (2% PFPE-PEG in HFE7500) or a lipid-mineral oil solution by dissolving lipid in mineral oil (refer to step 6.2.1)</li>
		<li>Prepare a total volume of 100 &#181;L of CFPS reaction by combining the corresponding reagents 2-18 from Table 4. Add CFPS reaction to 500 &#181;L of the previously prepared oil in a 1.5 mL tube and then, rub the tube vigorously on the tube rack 50x to form fine (water-in-oil) droplets. Incubate the tube at 30 &#176;C to perform the reaction. 
		NOTE: Simple microfluidics chips could also be used to generate homogenous droplets as well43.</li>
	</ol>
	</li>
	<li>Giant unilamellar vesicles (GUVs)
	<ol>
		<li>Preparing the lipid-mineral oil solution
		<ol>
			<li>Add 57 &#181;L of chloroform into a 4 mL glass vial and then add 18 &#181;L of 25 mg/mL 1-palmitoyl-2-oleoyl-glycerol-3-phosphocholine (POPC) lipids to form the chloroform lipid solution, achieving a final concentration of 8 mM (use other lipids with similar final concentrations). 
			NOTE: This mixing step was to ensure homogeneous mixing of different lipids.</li>
			<li>Evaporate the chloroform under an argon flow for 15 min, and then, further evaporate under vacuum for 1 h.</li>
			<li>Dissolve the resulting dry lipids in 1,500 &#181;L of mineral oil, reaching a final concentration of 400 &#181;M. Incubate the mixture overnight at room temperature.</li>
		</ol>
		</li>
		<li>Forming an interfacial lipid layer
		<ol>
			<li>Add 500 &#181;L of the outer solution (see Table 5) to a 1.5 mL tube, and slowly layer 250 &#181;L of lipid-mineral oil solution on top of the outer solution. Incubate at room temperature for 30 min to form a stable interfacial lipid layer.</li>
		</ol>
		</li>
		<li>Preparation of the inner solution
		<ol>
			<li>Mix all the reagents in Table 6 to form the preinner solution and keep it on ice until use. Complete the inner solution by adding T7RNAP, S30 extract, and DNA template into the preinner solution as reagents 16-18 listed in Table 4. 
			NOTE: Increasing encapsulated sucrose concentration above 250 mM might inhibit cell-free translation44.</li>
		</ol>
		</li>
		<li>Formation of GUVs
		<ol>
			<li>Add 50 &#181;L of inner solution to a 1.5 mL new tube containing 500 &#181;L of lipid-mineral oil, pipette up and down rapidly, and vortex vigorously.</li>
			<li>Leave the tube on ice for 10 min and slowly add 20 &#181;L of the emulsion mixture to the top of the oil phase in the 1.5 mL tube from step 6.2.2.</li>
			<li>Centrifuge at 800 &#215; g (use a centrifugation speed ranging from 100 &#215; g to 1000 &#215; g) for 10 min at 4 &#176;C and observe the formation of GUVs at the bottom of the tube. 
			NOTE: A higher specific centrifugation speed could be used; however, one would consider that the centrifugation speed could influence the size of formed GUVs45.</li>
			<li>Remove the upper oil phase.</li>
			<li>Aspirate 30 &#181;L of GUVs at the bottom of the tube carefully. Incubate the collected GUVs at 30 &#176;C. 
			NOTE: The optimal incubation temperature varies for different proteins.</li>
			<li>Use Confocal Laser Scanning Microscopy (LSM) to monitor the expression of fluorescent proteins.</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>Supported lipid bilayer (SLB)
	<ol>
		<li>Preparation of SLB chambers
		<ol>
			<li>Piranha-clean 24 x 24 mm #1.5 coverslips by adding seven drops of sulfuric acid and two drops of 50% hydrogen peroxide to the center of each cover slide. Incubate the reactants on the coverslips for at least 45 min; rinse thoroughly with ultrapure water.</li>
			<li>Assemble the reconstitution chamber by attaching a cut 0.5 mL microfuge tube onto the cleaned coverslips using optical glue cured under an ultraviolet lamp (365 nm) for 10 min to form a reaction chamber.</li>
		</ol>
		</li>
		<li>SLB formation
		<ol>
			<li>Dissolve 80 mol% 1,2-dioleoyl-sn-glycerol-3-phosphocholine (DOPC), 19.95 mol% 1,2-dioleoyl-sn-glycerol-3-phospho-L-serine (DOPS), and 0.05 mol% Atto488-DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine = DOPE), mix in chloroform, dry under mild nitrogen flow and vacuum for 1 h to remove the solvent completely.</li>
			<li>Rehydrate the dried lipid film in SLB buffer A, resulting in a final lipid concentration of 4 mg/mL.</li>
			<li>Vortex and sonicate the resulting samples until they become clear.</li>
			<li>Dilute 4 mg/mL of SUVs with 130 &#181;L of SLB buffer A, transfer 75 &#181;L of the suspension to the preformed reaction chambers, and incubate it on a heat block at 37 &#176;C for 1 min. Add 150 &#181;L of SLB buffer A to the reaction chamber for further incubation for 2 min.</li>
			<li>Wash the chamber with 2 mL of SLB buffer B (SLB buffer A without MgCl2) prior to a buffer exchange to the S30 buffer C with 0.4% (w/v) BSA for CFPS reactions, leaving 100 &#181;L of buffer inside the chamber to prevent the formed SLB from drying out.</li>
			<li>Remove the residual S30 buffer C and add the CFPS reaction mixture into the SLB chamber carefully. Incubate the chamber at 30 &#176;C and monitor the expression under a confocal laser scanning microscope.</li>
		</ol>
		</li>
	</ol>
	</li>
</ol>

CFPS Protocols for Micro-Compartmentalized Synthetic Cells

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

This manuscript outlines a modified Cell-Free Protein Synthesis (CFPS) system designed for use in various micro-compartments across synthetic cell platforms, including water-in-oil droplets, GUVs, and SLBs. We utilized the standard E. coli recombinant protein expression host strain, BL21(DE3), as the source extract for constructing protein-centric synthetic cell systems. This approach yielded approximately 0.5 mg/mL of protein across different compartments. While other customized extract source strains could be ...

The synthesis of synthetic or artificial cells has emerged as a highly prominent field of interdisciplinary research, attracting substantial interest from scientists across the domains of synthetic biology, chemistry, and biophysics. These scientists are united by the common goal of constructing a minimal living cell1,2,3. The rapid growth of this field has been in step with significant advancements in critical technologies, such as recombinant DNA manipulation4, biomimetic materials5, and microfabrication techniques for compartmentalization6, including the Cell-Free Protein Synthesis (CFPS) method7. CFPS systems encompass the essential cellular machinery for transcription and translation, providing the foundational framework for the development and integration of multifunctional artificial cells.
Although CFPS techniques are frequently used in the assembly of synthetic cells, developing a robust and tailored CFPS system for the assembly of various synthetic cell systems remains a complex challenge. Currently, numerous CFPS systems are available, derived from both prokaryotes and eukaryotes model organisms8, each specialized for particular applications in synthetic cell synthesis. Beyond their central roles in transcription and translation, CFPS systems vary in their main components and associated preparation procedures. These variations, which include differences in cell extracts, RNA polymerases, template preparation methods, and buffer compositions, are largely due to the distinct development trajectories pursued by research groups that have intensively optimized their systems for maximal protein yield.
Among the various components of the CFPS system, the cell extract is a critical enzymatic pool for transcription and translation, and thus a key determinant of CFPS performance9. Escherichia coli (E. coli)-based CFPS is the most commonly utilized system due to its status as the best-understood prokaryotic organism. Furthermore, a fully reconstituted CFPS system comprising individually purified proteins and ribosomes, known as PURE10, has been developed by Ueda&#39;s research group, which is particularly suited for applications requiring a clear background. Today, even E. coli-based CFPS systems have diversified, especially in terms of the source strains for the extrac11 and methods of preparation12,13, RNA polymerase14,15, energy sources16,17, and buffer systems18,19. The most frequently used strains include K12 and B strain derivatives, such as A1920, JM10921, BL21 (DE3)22, and Rossetta223, alongside their genetically modified counterparts.
Initially, E. coli strains with reduced RNase and protease activities were chosen to enhance mRNA stability and the stability of newly synthesized recombinant proteins, leading to increased final protein yields24. Subsequently, E. coli extracts were engineered to facilitate specific post-translational modifications, including glycosylation25, phosphorylation26, and lipidation27, were developed to achieve the above posttranslational modifications. Additionally, an array of additives such as molecular chaperons28 and chemical stabilizers have been incorporated to aid the folding of target proteins, contributing to the diversification of CFPS systems. The bacteriophage T7 RNA polymerase, known for its high processivity, is predominantly employed for transcription, although other polymerases such as SP629 have also been utilized. E. coli endogenous RNA polymerase has been adapted for the prototyping of genetic circuits leveraging sigma factors30. Lastly, a variety of energy precursors31,32,33 and different salts and buffer components19,34,35 have been systematically optimized to enhance productivity.
Besides the CFPS system itself, the encapsulation methods as well as compartmentalization materials are also vital for the successful synthetic cell assembly. Various systems that have been developed to successfully encapsulate the CFPS reaction include surfactant-stabilized water/oil droplets, lipid/polymer, and their hybrid unilamellar vesicles (with diameters ranging from 50 nm to several &#956;m), as well as planar-supported lipid bilayers. However, due to the complexed molecule content of the CFPS system, the success rate of encapsulation depends on specific cases, particularly for the formation of vesicles. To improve the success rate and efficiency of encapsulation of CFPS, various microfluid chips have been developed to facilitate the formation of both droplets and vesicles36. Nevertheless, additional chips and devices will need to be established.
This protocol delineates an E. coli CFPS system utilizing the BL21(DE3) strain, which is a commonly employed host for recombinant protein production. The protocol encompasses a detailed account of the cell extract preparation, template preparation, and standard expression optimization using a fluorescent reporter protein. Moreover, we present exemplary outcomes achieved by encapsulating the CFPS system within diverse micro-compartments, including monolayer droplets, double emulsion vesicles, and chambers situated atop supported lipid bilayers. Finally, we expound upon the pivotal procedural elements and the requisite conditions indispensable for the successful establishment of these CFPS systems within distinct environmental contexts.

<table border="1" fo:keep-together.within-page="1" fo:keep-with-next.within-page="always">
	<tbody>
		<tr>
			<td>1,2-dioleoyl-sn-glycero-3-phosphocholine(DOPC)</td>
			<td>Avanti</td>
			<td>850375P</td>
			<td></td>
		</tr>
		<tr>
			<td>1,2-dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt)(DOPS)</td>
			<td>Avanti</td>
			<td>840035P</td>
			<td></td>
		</tr>
		<tr>
			<td>1,4 dithiothreitol (DTT)</td>
			<td>Sigma-Aldrich</td>
			<td>1.11474</td>
			<td></td>
		</tr>
		<tr>
			<td>1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC)</td>
			<td>Avanti</td>
			<td>850457P</td>
			<td></td>
		</tr>
		<tr>
			<td>3,5-cyclic AMP (cAMP)</td>
			<td>Sigma-Aldrich</td>
			<td>A9501</td>
			<td></td>
		</tr>
		<tr>
			<td>50 mL tubes</td>
			<td>Eppendorf</td>
			<td>Eppendorf Tubes BioBased</td>
			<td></td>
		</tr>
		<tr>
			<td>50% hydrogen peroxide</td>
			<td>Sigma-Aldrich</td>
			<td>516813</td>
			<td></td>
		</tr>
		<tr>
			<td>Acetate</td>
			<td>Sigma-Aldrich</td>
			<td>A6283</td>
			<td></td>
		</tr>
		<tr>
			<td>Agar powder</td>
			<td>Sigma-Aldrich</td>
			<td>05040</td>
			<td></td>
		</tr>
		<tr>
			<td>Alanin</td>
			<td>Sigma-Aldrich</td>
			<td>A4349</td>
			<td></td>
		</tr>
		<tr>
			<td>Amicon Stirred Cells</td>
			<td>MerckMillipore</td>
			<td>UFSC05001</td>
			<td></td>
		</tr>
		<tr>
			<td>Ammonium acetate (NH4OAc)</td>
			<td>Sigma-Aldrich</td>
			<td>A7262</td>
			<td></td>
		</tr>
		<tr>
			<td>Arginin</td>
			<td>Sigma-Aldrich</td>
			<td>A4474</td>
			<td></td>
		</tr>
		<tr>
			<td>Asparagin</td>
			<td>Sigma-Aldrich</td>
			<td>A0884</td>
			<td></td>
		</tr>
		<tr>
			<td>Aspartat</td>
			<td>Sigma-Aldrich</td>
			<td>A5474</td>
			<td></td>
		</tr>
		<tr>
			<td>ATP</td>
			<td>Roche</td>
			<td>11140965001</td>
			<td></td>
		</tr>
		<tr>
			<td>Atto 488 DOPE</td>
			<td>Sigma-Aldrich</td>
			<td>67335</td>
			<td></td>
		</tr>
		<tr>
			<td>Atto 647N DOPE</td>
			<td>Sigma-Aldrich</td>
			<td>42247</td>
			<td></td>
		</tr>
		<tr>
			<td>Baffled Erlenmeyer flask</td>
			<td>Shuniu</td>
			<td>250 mL, 1000mL</td>
			<td></td>
		</tr>
		<tr>
			<td>Bovine Serum Albumin(BSA)</td>
			<td>Roche</td>
			<td>10711454001</td>
			<td></td>
		</tr>
		<tr>
			<td>Centrifugetube</td>
			<td>Eppendorf</td>
			<td>Eppendorf Tubes 3810X</td>
			<td></td>
		</tr>
		<tr>
			<td>Centrifugetube rack</td>
			<td>Eppendorf</td>
			<td>0030119819</td>
			<td></td>
		</tr>
		<tr>
			<td>Chemiluminescence and epifluorescence imaging system</td>
			<td>Uvitec</td>
			<td>Alliance Q9 Advanced</td>
			<td></td>
		</tr>
		<tr>
			<td>Chloroform</td>
			<td>Sigma-Aldrich</td>
			<td>288306</td>
			<td></td>
		</tr>
		<tr>
			<td>Confocal Laser Scanning Microscopy (LSM)</td>
			<td>ZEISS</td>
			<td>LSM 780</td>
			<td></td>
		</tr>
		<tr>
			<td>Countess Cell Counting Chamber Slides</td>
			<td>Thermo Fisher Scientific</td>
			<td>C10283</td>
			<td></td>
		</tr>
		<tr>
			<td>Coverslip</td>
			<td>Thermo Scientific</td>
			<td>Menzel BB02400500A113MNZ0</td>
			<td></td>
		</tr>
		<tr>
			<td>creatine kinase (CK)</td>
			<td>Roche</td>
			<td>10127566001</td>
			<td></td>
		</tr>
		<tr>
			<td>Creatine phosphate (CP)</td>
			<td>Sigma-Aldrich</td>
			<td>10621714001</td>
			<td></td>
		</tr>
		<tr>
			<td>Culture dish</td>
			<td>Huanqiu</td>
			<td>90 mm</td>
			<td></td>
		</tr>
		<tr>
			<td>Cystein</td>
			<td>Sigma-Aldrich</td>
			<td>C5360</td>
			<td></td>
		</tr>
		<tr>
			<td>Cytidine 5&#39;-triphosphate disodium salt (CTP)</td>
			<td>aladdin</td>
			<td>C101487</td>
			<td></td>
		</tr>
		<tr>
			<td>Dialysis membrane</td>
			<td>Spectrum</td>
			<td>Standard RC Tubing MWCO: 12-14 kD</td>
			<td></td>
		</tr>
		<tr>
			<td>E.Z.N.A. Cycle Pure Kit</td>
			<td>Omega Bio-Tek</td>
			<td>D6492-01</td>
			<td></td>
		</tr>
		<tr>
			<td>Electro-Heating Standing-Temperature Cultivator</td>
			<td>Yiheng instrument</td>
			<td>DHP-9602</td>
			<td></td>
		</tr>
		<tr>
			<td>Ethylenediaminetetraacetic acid(EDTA)</td>
			<td>Biosharp</td>
			<td>1100027</td>
			<td></td>
		</tr>
		<tr>
			<td>Fluorescent plate reader</td>
			<td>BioTek</td>
			<td>Synergy 2</td>
			<td></td>
		</tr>
		<tr>
			<td>Fluorinated oil</td>
			<td>Suzhou CChip scientific instrument</td>
			<td>2%HFE7500</td>
			<td></td>
		</tr>
		<tr>
			<td>Folinic acid</td>
			<td>Sigma-Aldrich</td>
			<td>47612</td>
			<td></td>
		</tr>
		<tr>
			<td>French Press</td>
			<td>G.Heinemann</td>
			<td>HTU-DIGI-Press</td>
			<td></td>
		</tr>
		<tr>
			<td>Glucose</td>
			<td>Sigma-Aldrich</td>
			<td>G7021</td>
			<td></td>
		</tr>
		<tr>
			<td>Glutamat</td>
			<td>Sigma-Aldrich</td>
			<td>G5667</td>
			<td></td>
		</tr>
		<tr>
			<td>Glutamin</td>
			<td>Sigma-Aldrich</td>
			<td>G5792</td>
			<td></td>
		</tr>
		<tr>
			<td>Glycerol</td>
			<td>Sigma-Aldrich</td>
			<td>G5516</td>
			<td></td>
		</tr>
		<tr>
			<td>Glycin</td>
			<td>Sigma-Aldrich</td>
			<td>G7126</td>
			<td></td>
		</tr>
		<tr>
			<td>Guanosine 5&#39;-triphosphate sodium salt hydrate(GTP)</td>
			<td>Roche</td>
			<td>10106399001</td>
			<td></td>
		</tr>
		<tr>
			<td>HEPES</td>
			<td>Sigma-Aldrich</td>
			<td>H3375</td>
			<td></td>
		</tr>
		<tr>
			<td>HiPrep Q FF 16/10</td>
			<td>Cytiva</td>
			<td>28936543</td>
			<td></td>
		</tr>
		<tr>
			<td>Histidin</td>
			<td>Sigma-Aldrich</td>
			<td>H6034</td>
			<td></td>
		</tr>
		<tr>
			<td>Isoleucin</td>
			<td>Sigma-Aldrich</td>
			<td>I5281</td>
			<td></td>
		</tr>
		<tr>
			<td>Isopropyl-&#946;-D-thiogalactopyranoside (IPTG)</td>
			<td>Sigma-Aldrich</td>
			<td>I5502</td>
			<td></td>
		</tr>
		<tr>
			<td>K2HPO4</td>
			<td>Sigma-Aldrich</td>
			<td>P8281</td>
			<td></td>
		</tr>
		<tr>
			<td>KH2PO4</td>
			<td>Sigma-Aldrich</td>
			<td>P5655</td>
			<td></td>
		</tr>
		<tr>
			<td>Leucin</td>
			<td>Sigma-Aldrich</td>
			<td>L6914</td>
			<td></td>
		</tr>
		<tr>
			<td>Lysin</td>
			<td>Sigma-Aldrich</td>
			<td>L5501</td>
			<td></td>
		</tr>
		<tr>
			<td>Magnesium acetate tetrahydrate (Mg(OAc)2 )</td>
			<td>Sigma-Aldrich</td>
			<td>M5661</td>
			<td></td>
		</tr>
		<tr>
			<td>Magnesium chloride(MgCl2)</td>
			<td>Sigma-Aldrich</td>
			<td>M2670</td>
			<td></td>
		</tr>
		<tr>
			<td>Methionin</td>
			<td>Sigma-Aldrich</td>
			<td>M8439</td>
			<td></td>
		</tr>
		<tr>
			<td>Microcentrifuge</td>
			<td>Eppendorf</td>
			<td>5424 R</td>
			<td></td>
		</tr>
		<tr>
			<td>Mineral oil</td>
			<td>Sigma-Aldrich</td>
			<td>M5904</td>
			<td></td>
		</tr>
		<tr>
			<td>Mini-PROTEAN Tetra Cell Systems</td>
			<td>Bio-Rad</td>
			<td>1645050</td>
			<td></td>
		</tr>
		<tr>
			<td>Multipurpose Centrifuge</td>
			<td>Eppendorf</td>
			<td>5810 R</td>
			<td></td>
		</tr>
		<tr>
			<td>NaN3</td>
			<td>Sigma-Aldrich</td>
			<td>S2002</td>
			<td></td>
		</tr>
		<tr>
			<td>Nucleic Acid &#38; Protein UV-Assay Measurements</td>
			<td>IMPLEN</td>
			<td>NanoPhotometer N60</td>
			<td></td>
		</tr>
		<tr>
			<td>NucleoBond Xtra Maxi kit for transfection-grade plasmid DNA</td>
			<td>MACHEREY-NAGEL</td>
			<td>740414.5</td>
			<td></td>
		</tr>
		<tr>
			<td>Nunc-Immuno MicroWell 96 well polystyrene plates</td>
			<td>Sigma-Aldrich</td>
			<td>P8616</td>
			<td></td>
		</tr>
		<tr>
			<td>PCR Thermal Cycler</td>
			<td>Eppendorf</td>
			<td>Mastercycler nexus</td>
			<td></td>
		</tr>
		<tr>
			<td>Peptone</td>
			<td>Sigma-Aldrich</td>
			<td>83059</td>
			<td></td>
		</tr>
		<tr>
			<td>Phenylalanin</td>
			<td>Sigma-Aldrich</td>
			<td>P8740</td>
			<td></td>
		</tr>
		<tr>
			<td>Phosphoenolpyruvat (PEP)</td>
			<td>GLPBIO</td>
			<td>GC44635</td>
			<td></td>
		</tr>
		<tr>
			<td>PMSF</td>
			<td>Sigma-Aldrich</td>
			<td>PMSF-RO</td>
			<td></td>
		</tr>
		<tr>
			<td>Polyethylene glycol 8000 (PEG 8000)</td>
			<td>Sigma-Aldrich</td>
			<td>89510</td>
			<td></td>
		</tr>
		<tr>
			<td>Potassium Acetate(KOAc)</td>
			<td>Sigma-Aldrich</td>
			<td>P5708</td>
			<td></td>
		</tr>
		<tr>
			<td>Potassium chloride(KCl)</td>
			<td>Sigma-Aldrich</td>
			<td>P9541</td>
			<td></td>
		</tr>
		<tr>
			<td>Potassium glutamate (K-glutamate)</td>
			<td>Sigma-Aldrich</td>
			<td>G1501</td>
			<td></td>
		</tr>
		<tr>
			<td>Potassium hydroxide(KOH)</td>
			<td>Sigma-Aldrich</td>
			<td>221473</td>
			<td></td>
		</tr>
		<tr>
			<td>Prolin</td>
			<td>Sigma-Aldrich</td>
			<td>P8865</td>
			<td></td>
		</tr>
		<tr>
			<td>Pyruvate kinase (PK)</td>
			<td>Sigma-Aldrich</td>
			<td>P9136</td>
			<td></td>
		</tr>
		<tr>
			<td>Serin</td>
			<td>Sigma-Aldrich</td>
			<td>S4311</td>
			<td></td>
		</tr>
		<tr>
			<td>Shaker</td>
			<td>Zhichushakers</td>
			<td>ZQZY-AF8</td>
			<td></td>
		</tr>
		<tr>
			<td>Sodium chloride(NaCl)</td>
			<td>Sigma-Aldrich</td>
			<td>S5886</td>
			<td></td>
		</tr>
		<tr>
			<td>Sodium hydroxide(NaOH)</td>
			<td>Sigma-Aldrich</td>
			<td>S5881</td>
			<td></td>
		</tr>
		<tr>
			<td>Sucrose</td>
			<td>aladdin</td>
			<td>S112226</td>
			<td></td>
		</tr>
		<tr>
			<td>Sulfuric acid</td>
			<td>Sigma-Aldrich</td>
			<td>339741</td>
			<td></td>
		</tr>
		<tr>
			<td>Syringe Filters</td>
			<td>Jinteng</td>
			<td>0.45 &#956;m</td>
			<td></td>
		</tr>
		<tr>
			<td>Test tube</td>
			<td>Shuniu</td>
			<td>20 mL</td>
			<td></td>
		</tr>
		<tr>
			<td>TGX FastCast Acrylamide Kit, 12%</td>
			<td>Bio-Rad</td>
			<td>#1610175</td>
			<td></td>
		</tr>
		<tr>
			<td>ThermoMixer</td>
			<td>Eppendorf</td>
			<td>ThermoMixer C</td>
			<td></td>
		</tr>
		<tr>
			<td>Threonin</td>
			<td>Sigma-Aldrich</td>
			<td>T8441</td>
			<td></td>
		</tr>
		<tr>
			<td>Tris base</td>
			<td>Sigma-Aldrich</td>
			<td>V900483</td>
			<td></td>
		</tr>
		<tr>
			<td>tRNA</td>
			<td>Roche</td>
			<td>10109550001</td>
			<td></td>
		</tr>
		<tr>
			<td>Tryptone</td>
			<td>Sigma-Aldrich</td>
			<td>T7293</td>
			<td></td>
		</tr>
		<tr>
			<td>Tryptophan</td>
			<td>Sigma-Aldrich</td>
			<td>T8941</td>
			<td></td>
		</tr>
		<tr>
			<td>Tyrosin</td>
			<td>Sigma-Aldrich</td>
			<td>T8566</td>
			<td></td>
		</tr>
		<tr>
			<td>UTP Trisodium salt (UTP)</td>
			<td>aladdin</td>
			<td>U100365</td>
			<td></td>
		</tr>
		<tr>
			<td>Vacuum Pump with Circulated Water System</td>
			<td>Zhengzhou Greatwall Scientific Industrial and Trade Co.Ltd</td>
			<td>SHB-<img alt="Equation 1" src="/files/ftp_upload/66626/66626eq01.jpg" style="margin: auto;" /></td>
			<td></td>
		</tr>
		<tr>
			<td>Valin</td>
			<td>Sigma-Aldrich</td>
			<td>V4638</td>
			<td></td>
		</tr>
		<tr>
			<td>Vortex Mixers</td>
			<td>Kylin-Bell</td>
			<td>Vortex QL-861</td>
			<td></td>
		</tr>
		<tr>
			<td>Water purification system</td>
			<td>MerckMillipore</td>
			<td>Direct ultrapure water (Type 1)</td>
			<td></td>
		</tr>
		<tr>
			<td>Yeast extract</td>
			<td>Sigma-Aldrich</td>
			<td>70161</td>
			<td></td>
		</tr>
		<tr>
			<td>&#946;-mercaptoethanol</td>
			<td>Sigma-Aldrich</td>
			<td>444203</td>
			<td></td>
		</tr>
	</tbody>
</table>

cell-free protein synthesis system for building synthetic cells

The Cell-Free Protein Synthesis (CFPS) system has been widely employed to facilitate the bottom-up assembly of synthetic cells. It serves as the host for the core machinery of the Central Dogma, standing as an optimal chassis for the integration and assembly of diverse artificial cellular mimicry systems. Despite its frequent use in the fabrication of synthetic cells, establishing a tailored and robust CFPS system for a specific application remains a nontrivial challenge. In this methods paper, we present a comprehensive protocol for the CFPS system, routinely employed in constructing synthetic cells. This protocol encompasses key stages in the preparation of the CFPS system, including the cell extract, template preparation, and routine expression optimization utilizing a fluorescent reporter protein. Additionally, we show representative results by encapsulating the CFPS system within various micro-compartments, such as monolayer droplets, double-emulsion vesicles, and chambers situated atop supported lipid bilayers. Finally, we elucidate the critical steps and conditions necessary for the successful assembly of these CFPS systems in distinct environments. We expect that our approach will facilitate the establishment of good working practices among various laboratories within the continuously expanding synthetic cell community, thereby accelerating progress in the field of synthetic cell development.

Author Spotlight: Optimizing CFPS Systems for Synthetic Cell Construction

Cell-Free Protein Synthesis System for Building Synthetic Cells

All our research focuses on cell-free synthetic biology. This involve bottom up assembly synthetic cells, functional and structured analysis of membrane proteins, protein engineering while incorporation of non conical amino acids and cell-free metabolic engineering. Currently besides cell-free protein synthesis, micro for edicts device by micro fabrication through soft lithography development of biocompatible materials and the general AI at the forefront technologies that drives the faster development of cell-free synthetic biology.The configuration presented as a protocol establishes a straightforward, yet robust system that is well shooted various micro compartment environments, including the Jove-ase, GOase, SL-based, that we should in our representative results. In the future, we will focus on the development of tailored cell-free systems, which enable the assembly and integration of different modular cell mimicry systems towards the ultimate goal of building a minimal cell.

For each new batch of cell extract and T7 RNA polymerase, it is recommended to perform a basic screening of both Mg2+ and K+ concentrations to ensure the optimal performance of the CFPS system. The fluorescence of superfolder GFP can serve as an indicator of the overall yield of the CFPS system under varying conditions, as illustrated in Figure 1A,B. Additionally, a parallel yield comparison of the CFPS system across different compartments is shown in <...

Read this Scientific Article Protocol about Cell-free Protein Synthesis System for Building Synthetic Cells at JoVE.com

This protocol describes the Cell-Free Protein Synthesis (CFPS) system used in constructing synthetic cells. It outlines key stages with representative results in different micro-compartments. The protocol aims to establish best practices for diverse laboratories in the synthetic cell community, advancing progress in synthetic cell development.

The Cell-Free Protein Synthesis (CFPS) system has been widely employed to facilitate the bottom-up assembly of synthetic cells. It serves as the host for ...

cell-free-protein-synthesis-system-for-building-synthetic-cells

Research

JoVE Journal

Biochemistry

1.4K Views.  Jiangsu Normal University. All our research focuses on cell-free synthetic biology. This involve bottom up assembly synthetic cells, functional and structured analysis of membrane proteins, protein engineering while incorporation of non conical amino acids and cell-free metabolic engineering. Currently besides cell-free protein synthesis, micro for edicts device by micro fabrication through soft lithography development of biocompatible materials and the general AI at the forefront technologies that drives the faster de...

Video: Author Spotlight: Optimizing CFPS Systems for Synthetic Cell Construction

Preparation of Extracts and T7 RNA Polymerase for Cell-Free Protein Synthesis Systems

To begin, obtain pre-cultured cells and wash them two times with 35 milliliters of pre-chilled S30 buffer A.Pellet the cells. And re-suspend them in S30 buffer B.For disrupting the cells, transfer the cell suspension to a French press metal disruption chamber and secure it in the hydraulic platform with the safety lock. Turn on the hydraulic pump and start the disruption.Control the outlet valve to collect the cell suspension in a new 50-milliliter tube, maintaining the pressure at 17, 000 pounds per square inch. Centrifuge the resulting lysate at 30, 000G for 30 minutes at four degrees Celsius and collect the supernatant. Centrifuge again and incubate the collected supernatant with 0.3 volume of pre-incubation buffer with gentle shaking at 37 degrees Celsius for 80 minutes.Dialyze the resulting runoff mixture for two hours against two liters of S30 buffer C overnight at four degrees Celsius. Centrifuge the dialyzed sample and aliquot the supernatant. Flash freeze the samples immediately in liquid nitrogen.After pelleting the cultured cells, re-suspend them in 30 milliliters of T7 buffer A.Disrupt the cells in one pass through the French press at 15, 000 pounds per square inch, and centrifuge the lysate to remove the cell debris. Add streptomycin sulfate drop by drop to the supernatant to reach a final concentration of 4%After a short incubation on ice, centrifuge the lysate as before. Load the filtered samples onto a strong anion exchange column.After washing the column, elute the sample with 10 column volumes of T7 buffer C at a flow rate of three milliliters per minute. Add glycerol to reach a final concentration of 10%and subject the resulting mixture to ultrafiltration to obtain a final concentration of three to four milligrams per milliliter.

Lipid Encapsulation Procedure to Obtain Cell-Free Protein Synthesis System

To begin, obtain a surfactant containing fluorinated, or a lipid mineral oil solution. Add cell-free protein synthesis or CFPS mixture to 500 microliters of the previously prepared oil in a 1.5 milliliter tube, and rub the tube vigorously on the tube rack 50 times to form fine droplets. For giant unilamellar vesicle, or GUV preparation, add 57 microliters of chloroform into a four milliliter glass vial, followed by 18 microliters of lipids, to a final concentration of eight millimolar.Evaporate the chloroform under an argon flow for 15 minutes, and then under vacuum for one hour. Dissolve the resulting dry lipids in 1, 500 microliters of mineral oil to reach a final concentration of 400 micromolar. To obtain an interfacial lipid layer, slowly layer two 50 microliters of lipid mineral oil solution on top of 500 microliters of the outer solution, taken in a 1.5 milliliter tube.Incubate at room temperature for 30 minutes to form a stable interfacial lipid layer. For the inner solution, add T7 RNA polymerase S30 extract, and DNA template into the cold pre inner solution. Mix 50 microliters of inner solution, and 500 microliters of lipid mineral oil, and vortex vigorously.Leave the tube on ice for 10 minutes, and slowly add 20 microliters of this emulsion mixture to the top of the previously prepared oil phase in the 1.5 milliliter tube. Centrifuge at about 800 G for 10 minutes at four degrees celsius. And observe the formation of GUVs at the bottom of the tube.After removing the upper oil phase, aspirate 30 microliters of GUVs from the bottom of the tube carefully. Add seven drops of sulfuric acid, and two drops of 50%hydrogen peroxide to the center of a cover slide, and incubate for 45 minutes. After rinsing thoroughly with ultrapure water, glue it to a cut 0.5 milliliters microfuge tube.Cure under an ultraviolet lamp for 10 minutes to form a reaction chamber. Next, add 75 microliters of the small unilamellar vesicles, or SUV suspension to the preformed reaction chambers, and incubate it on a heat block at 37 degrees celsius for one minute. Then, add 150 microliters of supported lipid bilayer, or SLB buffer A to the reaction chamber for an additional two minute incubation.Wash the chamber with hundred microliters of SLB buffer B prior to a buffer exchange to the S 30 buffer C, leaving 100 microliters of buffer inside the chamber to prevent the form's supported lipid bilayer from drying out. Using confocal laser scanning microscopy, the expression of green fluorescent protein and mCherry encapsulated in droplets was successfully captured. The fluorescence image of encapsulated CFPS within GUVs showed expression of super folder green fluorescent protein within the labeled lipid bilayer.